[Myths and evidence on the use of botulinum toxin: spasticity in adults and in children with cerebral palsy].

Autor:	Martinez-Castrillo JC; Hospital Universitario Ramon y Cajal, 28034 Madrid, Espana., Pena-Segura JL; HUMS. Hospital Universitario Miguel Servet, 50009 Zaragoza, Espana., Sanz-Cartagena P; Hospital de Mataro. Consorci Sanitari del Maresme, 08304 Mataro, Espana., Alonso-Curco X; Hospital Sant Joan de Deu, Esplugues de Llobregat, Espana., Arbelo-Gonzalez JM; Hospital Universitario Insular de Gran Canaria, 35016 Las Palmas de Gran Canaria, Espana., Arriola-Pereda G; Hospital Universitario de Guadalajara, Guadalajara, Espana., Coll-Bosch MD; Hospital Parc Tauli, Sabadell, Espana., Conejero-Casares JA; Hospital Universitario Virgen Macarena, 41003 Sevilla, Espana., Garcia-Ribes A; Hospital Universitario de Cruces. Universidad del Pais Vasco, 48903 Baracaldo, Espana., Jauma-Classen S; Hospital General Universitari de Bellvitge, 08907 L'Hospitalet de Llobregat, Espana., Pagonabarraga J; Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Espana., Vidal-Valls J; Centro Piloto de Paralisis Cerebral Arcangel San Gabriel (ASPACE), Barcelona, Espana., Garcia-Ruiz PJ; Fundacion Jimenez Diaz, 28040 Madrid, Espana.
Jazyk:	Spanish; Castilian
Zdroj:	Revista de neurologia [Rev Neurol] 2017 May 16; Vol. 64 (10), pp. 459-470.
Abstrakt:	Introduction: Spasticity is a medical problem with a high incidence that significantly impact on the quality of life of patients and their families. Aim: To analyze and to answer different questions about the use of botulinum toxin type A (BTA) in our clinical practice. Development: A group of experts in neurology develop a list of topics related with the use of BTA. Two big groups were considered: spasticity in adults and in children with cerebral palsy. A literature search at PubMed for English, French, and Spanish language articles published up to June 2016 was performed. The manuscript was structured as a questionnaire that includes those questions that, according to the panel opinion, could generate more controversy or doubt. The initial draft was reviewed by the expert panel members to allow for modifications, and after subsequent revisions for achieving the highest degree of consensus, the final text was then validated. Different questions about diverse aspects of spasticity in adults, such as methods for evaluating spasticity, infiltration techniques, doses, number of infiltration points, etc. Regarding spasticity in children with cerebral palsy, the document included questions about minimum age of infiltration, methods of analgesia, etc. Conclusions: This review is a tool for continuous training for neurologist and rehabilitation specialist and residents of both specialties, about different specific areas of the management of BTA.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu